Topics

Hydroxychloroquine Use For COVID-19 Coronavirus Shows No Benefit In First Small—But Limited—Controlled Trial

04:31 EDT 25 Mar 2020 | Forbes

The study’s small size and other weaknesses mean it does not offer a lot of helpful information in determining the possible utility of hydroxychloroquine, according to experts who reviewed the study.

Original Article: Hydroxychloroquine Use For COVID-19 Coronavirus Shows No Benefit In First Small—But Limited—Controlled Trial

NEXT ARTICLE

More From BioPortfolio on "Hydroxychloroquine Use For COVID-19 Coronavirus Shows No Benefit In First Small—But Limited—Controlled Trial"

Quick Search